• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Ontario Health Extracorporeal Shockwave Therapy for Peyronie's Disease
2021     Ontario Health Blue Light (Fluorescence) Cystoscopy With Hexaminolevulinate Hydrochloride in Non-muscle Bladder Cancer
2021     Ontario Health Internet-Delivered Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder and Acute Stress Disorder
2021     Ontario Health iStent for People With Open angle Glaucoma
2021     Ontario Health DPYD Genotyping in Patients with Cancer Treated with Fluoropyrimidines
2021     Ontario Health Multi-gene Pharmacogenomic Testing to Guide Medication Selection for People with Major Depression
2021     Ontario Health Molecular Testing for Thyroid Nodules with Atypical Cells of Indeterminate Significance
2021     Ontario Health Nonthermal Minimally Invasive Treatments for Varicose Veins
2021     Ontario Health Prostatic Artery Embolization for Benign Prostatic Hyperplasia
2021     Ontario Health Skin Substitutes for Adults with Diabetic Foot Ulcers and Venous Leg Ulcers
2021     Ontario Health Repetitive Transcranial Magnetic Stimulation (rTMS) for People with Treatment-Resistant Depression
2021     Ontario Health Pigmented Lesion Assay for Suspected Melanoma Lesions
2021     Ontario Health Use of B-type Natriuretic Peptide and N Terminal-pro B-type Natriuretic Peptide as Diagnostic Tests in People with Suspected Heart Failure
2021     Ontario Health Vaginal Pessaries for Pelvic Organ Prolapse and Stress Urinary Incontinence
2020     Technology Assessment at SickKids (TASK) Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endovascular treatment of varicose veins by radiofrecuency ablation or cyanoacrylate closure]
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Swiss Federal Office of Public Health (FOPH) Chondroitin Sulfate in Osteoarthritis
2020     NIHR Health Technology Assessment programme Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Leadless pacemaker for right ventricle pacing (Update 2020)
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS. Update 2020
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
2020     Ontario Health Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Intrauterine ultrasound-guided transcervical radiofrequency ablation
2020     Center for Drug Evaluation (CDE) The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancer
2020     Ontario Health Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2020     Ontario Health Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Health Services Research in Oncology. Part I: End-of-Life Care
2020     Austrian Institute for Health Technology Assessment (AIHTA) Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 1; Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 2 (Appendix)
2020     Ontario Health 10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020     Ontario Health Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020     Ontario Health Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020     Ontario Health 5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020     Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020     Ontario Health Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020     Health Technology Wales (HTW) The clinical effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis
2020     Swiss Federal Office of Public Health (FOPH) Glinides and glitazones in the treatment of type 2 diabetes
2020     Health Technology Wales (HTW) Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020     Health Technology Wales (HTW) Virtual reality therapy for the management of procedure-related pain
2020     Health Technology Wales (HTW) Remote monitoring of blood glucose in women with gestational diabetes
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Chloroquine et Hydroxychloroquine dans le traitement de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19 : Complément d’informations du 22 Mai 2020
2020     Andalusian Health Technology Assessment Area (AETSA) Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) DISINFECTION CHAMBERS/TUNNELS IN THE CONTEXT OF COVID-19 PANDEMIC
2020     Andalusian Health Technology Assessment Area (AETSA) Genetic risk prediction test for cardiovascular disease
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020     NIHR Health Technology Assessment programme Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020     NIHR Health Technology Assessment programme Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020     NIHR Health Technology Assessment programme Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020     NIHR Health Services and Delivery Research programme Medication management in older people: the MEMORABLE realist synthesis
2020     NIHR Health Technology Assessment programme Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2020     Norwegian Institute for Public Health Abdominal aorta aneurysm (AAA) screening of men aged 65
2020     NIHR Health Technology Assessment programme Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020     NIHR Health Services and Delivery Research programme Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2020     Ontario Health Proton Beam Therapy for Cancer
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis and Low Surgical Risk
2020     Ontario Health Automated CT Perfusion Imaging to Aid in the Selection of Patients With Acute Ischemic Stroke for Mechanical Thrombectomy
2020     Ontario Health Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions
2020     Ontario Health Noninvasive Fetal RhD Blood Group Genotyping
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     NIHR Health Technology Assessment programme Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019     NIHR Horizon Scanning Centre (NIHR HSC) An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     NIHR Health Technology Assessment programme Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019     NIHR Public Health Research (PHR) programme Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019     Adelaide Health Technology Assessment (AHTA) Alpha Thalassaemia genetic testing
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019     Swiss Federal Office of Public Health (FOPH) Assessment of knee arthroscopy for the treatment of degenerative changes
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annulus Fibrosus Repair after lumbar discectomy